Will you have unlimited access to your clinician, preferably through video calls
For people with autoimmune conditions that affect the gut, this is particularly relevant
Promising data doesnt always equal better outcomes IRL
The GLP-1 plotter tool can help track progress visually over the course of a long protocol
Postmenopausal women experience a two- to three-fold increase in cardiometabolic risk, underscoring the need for targeted interventions. (Mauvais-Jarvis et al., 2017) Not All GLP-1 Agonists Are the Same Todays GLP-1 therapies vary in structure, receptor affinity, and clinical profile, and these nuances may matter for midlife women: Exenatide (Byetta, Bydureon): Derived from Gila monster venom peptide
Exercise improves insulin sensitivity, regulates hunger signals, and supports lean muscle retention